Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Aplenc

Showing results (161-170 of 254) with videos related to

Pageof 26
Sort By:
Blood|April 9, 2014
Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantationRichard Aplenc, Mei-Jie Zhang, Lillian Sung, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 2013
IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonistNuala J Meyer, Rui Feng, Mingyao Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2017
Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology GroupKatherine Tarlock, Todd A Alonzo, Michael R Loken, et al.
Blood|April 16, 2017
Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group reportMarijana Vujkovic, Edward F Attiyeh, Rhonda E Ries, et al.
Blood Advances|May 12, 2023
CD38 as a pan-hematologic target for chimeric antigen receptor T cellsTina Glisovic-Aplenc, Caroline Diorio, John A Chukinas, et al.
Blood|May 17, 2013
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapyDavid T Teachey, Susan R Rheingold, Shannon L Maude, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 3, 2014
Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantationEdward Cantu, Rupal J Shah, Wei Lin, et al.
The Lancet. Haematology|September 24, 2021
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trialsAllison Barz Leahy, Haley Newman, Yimei Li, et al.
Blood Advances|December 7, 2020
Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology GroupKaren M Chisholm, Amy E Heerema-McKenney, John K Choi, et al.
Proteomics. Clinical Applications|June 8, 2023
Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology GroupFieke W Hoff, Yihua Qiu, Brandon D Brown, et al.
Pageof 26

Showing results (161-170 of 254) with videos related to

Sort By:
Pageof 26
Blood|April 9, 2014
Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantationRichard Aplenc, Mei-Jie Zhang, Lillian Sung, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 2013
IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonistNuala J Meyer, Rui Feng, Mingyao Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2017
Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology GroupKatherine Tarlock, Todd A Alonzo, Michael R Loken, et al.
Blood|April 16, 2017
Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group reportMarijana Vujkovic, Edward F Attiyeh, Rhonda E Ries, et al.
Blood Advances|May 12, 2023
CD38 as a pan-hematologic target for chimeric antigen receptor T cellsTina Glisovic-Aplenc, Caroline Diorio, John A Chukinas, et al.
Blood|May 17, 2013
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapyDavid T Teachey, Susan R Rheingold, Shannon L Maude, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 3, 2014
Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantationEdward Cantu, Rupal J Shah, Wei Lin, et al.
The Lancet. Haematology|September 24, 2021
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trialsAllison Barz Leahy, Haley Newman, Yimei Li, et al.
Blood Advances|December 7, 2020
Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology GroupKaren M Chisholm, Amy E Heerema-McKenney, John K Choi, et al.
Proteomics. Clinical Applications|June 8, 2023
Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology GroupFieke W Hoff, Yihua Qiu, Brandon D Brown, et al.
Pageof 26